CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2024		37,574,538
Beginning balances at Dec. 31, 2024	$ 428,678	$ 4	$ 558,061	$ (43)	$ (129,344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		40,984
Issuance of common stock upon exercise of stock options	350		350
Vesting of early exercised options (in shares)		1,676
Vesting of early exercised options	14		14
Vesting of restricted stock units (in shares)		325,085
Stock‑based compensation	5,087		5,087
Other comprehensive income (loss)	480			480
Net loss	(17,349)				(17,349)
Ending balances (in shares) at Mar. 31, 2025		37,942,283
Ending balances at Mar. 31, 2025	$ 417,260	$ 4	563,512	437	(146,693)
Beginning balances (in shares) at Dec. 31, 2025	38,284,221	38,284,221
Beginning balances at Dec. 31, 2025	$ 306,133	$ 4	578,571	652	(273,094)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	10,104	10,104
Issuance of common stock upon exercise of stock options	$ 100		100
Vesting of restricted stock units (in shares)		526,291
Stock‑based compensation	4,744		4,744
Other comprehensive income (loss)	(406)			(406)
Net loss	$ (39,717)				(39,717)
Ending balances (in shares) at Mar. 31, 2026	38,820,616	38,820,616
Ending balances at Mar. 31, 2026	$ 270,854	$ 4	$ 583,415	$ 246	$ (312,811)